Results 131 to 140 of about 32,097 (251)

Topical Povidone Iodine 2.5% Versus 5% for Endophthalmitis Prophylaxis During Intravitreal Injections. [PDF]

J Ophthalmol
Ajlan RS, Dalla S, Parikh RJ, Pfannenstiel MM, Champion MT, Rahman MA, Diaz FJ.   +6 more
europepmc   +1 more source

Cooling Anesthesia for Intravitreal Injections - A Review. [PDF]

Clin Ophthalmol, 2023
Chandrasekaran PR, Aziz AA, Khan H, Khanani AM.   +3 more
europepmc   +1 more source

Discordance Among Patients and Ophthalmologists Regarding the Burden of Intravitreal Injections. [PDF]

Clin Ophthalmol
Robinson K, Cooper SJ, Persaud S, Frederick JL, Singh RP.   +4 more
europepmc   +1 more source

Effect of Repeated Intravitreal Injections in Glaucoma Spectrum Diseases [Response to Letter]. [PDF]

Clin Ophthalmol, 2023
Vilares-Morgado R, Ferreira AM, Rocha-Sousa A, Carneiro Â, Barbosa-Breda J.   +4 more
europepmc   +1 more source

Towards greener intravitreal injections: the Oxford Eye Hospital experience. [PDF]

Eye (Lond)
Ong AY, Buckley TMW, Birtel J, de Silva SR, Stone N, Charbel Issa P.   +5 more
europepmc   +1 more source

Anxiety Levels Before Intravitreal Injections. [PDF]

Beyoglu Eye J
Ertan E, Simsek M, Dogan M.
europepmc   +1 more source

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). [PDF]

BMJ Open Ophthalmol, 2022
Wang R, McClard CK, Laswell S, Mahmoudzadeh R, Salabati M, Ammar M, Vannavong J, Aziz AA, Ewald A, Calvanese AV, Lehman EB, Fried S, Windham V, Strutt A, Saroj N, Khanani AM, Eichenbaum DA, Regillo C, Wykoff CC.   +18 more
europepmc   +1 more source

Optimizing pre-injection preparation to reduce endophthalmitis after intravitreal injection

, 2020
Farzad Jamshidi, Michelle C. Callegan, Vinay Shah, Sun Young Lee   +3 more
openalex   +1 more source

Bilateral Sterile Intraocular Inflammation Following Intravitreal Aflibercept 8 mg Injections: A Case Report [PDF]

Ram Cohen, Tomer Kerman, Omer Trivizki
openalex   +1 more source

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study [PDF]

, 2015
Kai Januschowski, Spyridon Dimopoulos, Peter Szurman, Nicolas Feltgen, Bernhard Spitzer, Amelie Pielen, Matúš Rehák, Georg Spital, Bevacizumab Study Group Venous Occlusion, Carsten H. Meyer, Gesine Szurman   +10 more
openalex   +1 more source